ARHGAP9 (Homo sapiens) in pDONR221 (Gateway donor/master vector)

Explanation of Terms

Gene:
Gene Symbol:  ARHGAP9
Gene Name:  Rho GTPase activating protein 9
Original Clone ID:
FLH194246.01L
Keyword:
None
Species:
Homo sapiens
Type:
cDNA
Vector Name:
pDONR221
Format: 
FUSION
Source:
HIP
Description:
None
Comments:
None
Mutation / Discrepancy:
No / No
Publications:
None
Authors:
HIP
HsCD00040471
Price: 
Login for Pricing
AVAILABLE
No restriction
Special MTA: None
Insert sequence: 2250nts
Open reading frame: 1 to 2250

ATGCTATCCAGCCGGTGGTGGCCAAGTTCCTGGGGGATCCTAGGGCTGGGCCCCCGAAGC
CCTCCTCGGGGATCCCAGCTCTGTGCCCTCTATGCCTTTACTTATACTGGGGCAGATGGC
CAGCAGGTGTCTCTGGCTGAAGGGGATAGGTTCCTACTGCTTCGAAAGACCAACTCCGAC
TGGTGGTTGGCAAGACGCCTAGAAGCTCCCTCCACCTCTCGACCCATCTTCGTCCCAGCA
GCCTATATGATAGAGGAATCCATCCCTTCCCAGAGTCCAACTACCGTCATCCCCGGCCAA
TTGCTCTGGACTCCTGGGCCGAAGTTGTTTCATGGTTCCCTGGAGGAGTTGTCTCAGGCC
CTCCCAAGCAGGGCTCAGGCTAGCTCGGAGCAGCCTCCTCCACTTCCCCGCAAAATGTGT
AGGAGCGTCAGCACTGACAATCTGAGCCCCAGCTTTCTGAAGCCTTTCCAGGAAGGACCA
AGCGGAAGATCCCTCTCCCAGGAAGACTTGCCGTCAGAAGCCAGTGCCAGCACAGCAGGC
CCCCAGCCCCTCATGTCAGAGCCCCCTGTGTACTGTAACCTGGTGGACCTTCGCCGCTGT
CCTCGGTCCCCACCCCCAGGCCCTGCATGCCCCCTGCTGCAGAGGCTGGATGCCTGGGAG
CAGCACCTGGACCCCAACTCTGGACGCTGCTTCTACATAAATTCACTGACTGGCTGCAAG
TCCTGGAAGCCCCCGCGCCGCAGTCGCAGCGAGACGAACCCTGGCTCCATGGAGGGGACA
CAGACCCTGAAGAGGAACAATGATGTCCTGCAACCTCAGGCAAAGGGCTTCAGATCTGAC
ACAGGGACCCCAGAACCGCTTGACCCACAGGGTTCACTCAGCCTCAGCCAACGCACCTCG
CAGCTTGACCCTCCAGCCTTGCAGGCCCCTCGACCTCTGCCGCAGCTCCTGGACGACCCC
CATGAGGTGGAAAAGTCGGGTCTGCTCAACATGACCAAGATTGCCCAAGGGGGGCGCAAG
CTCAGGAAGAACTGGGGCCCGTCTTGGGTGGTGTTAACGGGTAACAGCCTGGTGTTCTAC
CGAGAGCCACCGCCGACAGCGCCCTCCTCAGGCTGGGGACCAGCGGGTAGCCGGCCCGAA
AGTAGCGTGGACCTGCGCGGGGCGGCCCTGGCGCACGGCCGCCACCTGTCCAGCCGCCGC
AACGTCCTGCACATCCGCACGATCCCTGGCCACGAGTTCCTGCTGCAGTCGGACCACGAG
ACAGAGCTGCGAGCCTGGCACCGCGCGCTGCGGACTGTCATCGAGCGGCTGGTTAGATGG
GTGGAGGCCCGGAGGGAGGCTCCGACCGGCCGGGACCAAGGGAGTGGGGATCGGGAGAAC
CCCCTGGAGCTGCGTCTGTCGGGCTCTGGACCCGCGGAGCTGAGCGCCGGGGAGGACGAA
GAAGAGGAGTCGGAGCTGGTGTCCAAGCCGCTGCTGCGCCTCAGCAGCCGCCGGAGCTCC
ATTCGGGGGCCCGAAGGCACCGAGCAGAACCGCGTGCGCAACAAACTAAAGCGGCTCATC
GCGAAGAGACCGCCCTTACAAAGCCTGCAGGAGCGGGGTCTGCTCCGAGACCAGGTGTTC
GGCTGCCAGTTGGAATCACTCTGCCAGCGGGAAGGAGACACGGTGCCCAGCTTTTTGCGG
CTCTGCATTGCTGCTGTGGATAAAAGAGGTCTAGATGTGGATGGCATTTATCGGGTGAGC
GGGAACTTGGCAGTGGTCCAGAAGCTTCGCTTTCTGGTGGACAGAGAGCGTGCGGTCACC
TCCGATGGGAGGTATGTGTTCCCAGAACAGCCAGGACAAGAAGGTCGGTTAGATTTGGAC
AGTACTGAGTGGGATGACATTCATGTGGTCACCGGAGCCCTGAAGCTTTTTCTCCGGGAG
CTGCCCCAGCCTCTGGTGCCACCACTGCTGCTGCCCCATTTCCGTGCTGCCCTTGCACTC
TCCGAATCAGAGCAGTGCCTCTCTCAGATACAAGAATTAATAGGCTCAATGCCAAAGCCC
AACCATGACACTCTACGGTACCTCCTGGAGCATTTATGCAGGGTGATAGCACACTCAGAT
AAGAATCGCATGACACCCCACAACCTGGGAATTGTGTTTGGACCAACCCTGTTTCGGCCA
GAGCAGGAGACATCTGACCCAGCAGCCCATGCTCTCTACCCAGGGCAGCTGGTCCAGCTG
ATGCTCACCAACTTCACCAGCCTCTTCCCC

Protein sequence predicted based on nucleotide sequence

MLSSRWWPSSWGILGLGPRSPPRGSQLCALYAFTYTGADGQQVSLAEGDRFLLLRKTNSD
WWLARRLEAPSTSRPIFVPAAYMIEESIPSQSPTTVIPGQLLWTPGPKLFHGSLEELSQA
LPSRAQASSEQPPPLPRKMCRSVSTDNLSPSFLKPFQEGPSGRSLSQEDLPSEASASTAG
PQPLMSEPPVYCNLVDLRRCPRSPPPGPACPLLQRLDAWEQHLDPNSGRCFYINSLTGCK
SWKPPRRSRSETNPGSMEGTQTLKRNNDVLQPQAKGFRSDTGTPEPLDPQGSLSLSQRTS
QLDPPALQAPRPLPQLLDDPHEVEKSGLLNMTKIAQGGRKLRKNWGPSWVVLTGNSLVFY
REPPPTAPSSGWGPAGSRPESSVDLRGAALAHGRHLSSRRNVLHIRTIPGHEFLLQSDHE
TELRAWHRALRTVIERLVRWVEARREAPTGRDQGSGDRENPLELRLSGSGPAELSAGEDE
EEESELVSKPLLRLSSRRSSIRGPEGTEQNRVRNKLKRLIAKRPPLQSLQERGLLRDQVF
GCQLESLCQREGDTVPSFLRLCIAAVDKRGLDVDGIYRVSGNLAVVQKLRFLVDRERAVT
SDGRYVFPEQPGQEGRLDLDSTEWDDIHVVTGALKLFLRELPQPLVPPLLLPHFRAALAL
SESEQCLSQIQELIGSMPKPNHDTLRYLLEHLCRVIAHSDKNRMTPHNLGIVFGPTLFRP
EQETSDPAAHALYPGQLVQLMLTNFTSLFP

Coding Sequence Details

Insert Sequence Verified?:
Y
Verification Method:
Sequence Verification
Reference Sequence Annotations:
End on reference sequence 2659
Start on reference sequence 407
Mutations:
None
Discrepancy:
None
5' Linker Sequence:
None
3' Linker Sequence:
None

Recommended Growth Condition:

Distributed in bacterial strain:
DH5-alpha T1 phage resistant
Antibiotic Selection:
Host Type:  bacterial    Marker:  kanamycin
Bacterial Selection Condition: 50ug/mL kanamycin
Growth Condition: Growth with the single antibiotic in LB at 37 degrees is recommended.
Comments: Conditions for Gateway-type vectors in recombined (with insert) form and other kanamycin resistant vectors.
Protein Expression Results:
None
Recommended expression in:
Not Applicable